Genoa Ventures Founder and Managing Partner, Jenny Rooke, has been honored by the San Francisco Business Times as one of the Most Influential Women in Bay Area Business of 2021.
Read More
We are honored to be named to Inc Magazine’s 2021 Founder-Friendly Investors, a list of the best PE and VC firms with a track record of success backing entrepreneurs. It’s a privilege to help entrepreneurs build their vision into world-changing ideas. See the full list here.
Read More
"It's a hard way of living. It's a lot more work. There's all the science risk of a therapeutic — it may or may not work, the complexity of the biology — and all the execution slog of a real, scalable market."
Read More
Listen as our founder Jenny Rooke is interviewed by Luke Timmerman for The Long Run, a biotech podcast.
Read More
Stemson Therapeutics announced today the closing of a DCVC Bio-led $15 million Series A financing to advance development of Stemson’s proprietary therapeutic solution to cure hair loss. Genoa Ventures, AbbVie Ventures and other investors join in supporting Stemson’s efforts to restore human hair growth with a novel cell regeneration technology using the patient’s own cells to generate new hair follicles.
Read More
“We really try to meet them where they’re at in being able to convey what’s important about their technology and what they want to build as a company and then over the course of the relationship prepare them to tell that story to investors and the world at large,” she said. “There’s a meaningful role to be played as sort of a translator between the business and scientific fundamentals, and the story that people need to hear.”
Read More
We are proud to have Genoa’s partnership with Intabio recognized as a collaborative and differentiated way to empower our portfolio companies and drive to successful exits.
Read More
Congratulations to co-Founders Lena Wu, PhD, CEO, and Erik Gentalen, CTO, and the Intabio team on its acquisition by SCIEX. Genoa is privileged to have been partners in your journey from the beginning!
Read More
One-size-fits-all doesn’t work in medicine. This episode explains how doctors are now taking patients’ unique variables—like genetic makeup—into account when designing care.
Read More
The TechCrunch List is a verified, curated list of investors who have demonstrated a recent commitment to first checks and leading rounds from seed through growth, organized by market vertical.
Read More
Jenny Rooke of Genoa Ventures joins Nick Moran at The Full Ratchet to discuss Seed Investing at the Intersection of Biology & Technology.
Read More
March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.
Read More
Erik is joined by Jenny Rooke (@drjennyrooke), Managing Director at Genoa Ventures, and Jared Seehafer (@seehafer), Village Global Network Leader and CEO and co-founder of Enzyme.
Read More
Venture capitalists see a steady stream of people asking for money and currying favor. This can inflate the ego to unhealthy proportions. The best VCs, however, don’t let all that get to their head. They also don’t just write checks. They help entrepreneurs.
Read More